Floatz logo

Therapeutic Asset Ratings

1,553 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pembrolizumab
Pediatric AML
Joanna YiEarly P1C (39)
Pembrolizumab
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer CenterEarly P1C (39)
Pentoxifylline
Mucositis
Tanta UniversityEarly P1C (39)
Personalized Neoantigen Tumor Vaccine
Chemotherapy-intolerant
Ruijin HospitalEarly P1C (39)
Phentolamine
Vasoconstriction
University of Missouri-ColumbiaEarly P1C (39)
Phentolamine
Vasodilation
University of Missouri-ColumbiaEarly P1C (39)
Pioglitazone
Hyperinsulinism
Rambam Health Care CampusEarly P1C (39)
PITTSBURGH COMPOUND B UNLABELLED
Tauopathies
University of PennsylvaniaEarly P1C (39)
POLIGLUSAM MEDIUM-HIGH MOLECULAR WEIGHT (200-800 MPA.S)
Cirrhosis Of Liver
British University In EgyptEarly P1C (39)
Posaconazole
Adult Glioblastoma
Milton S. Hershey Medical CenterEarly P1C (39)
Posaconazole
Brain Glioblastoma
Milton S. Hershey Medical CenterEarly P1C (39)
Pralatraxate
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
Pralatraxate
T-Cell And NK-Cell Neoplasm
New York Medical CollegeEarly P1C (39)
PREDNISOLONE SODIUM SUCCINATE
Pediatric AML
Joanna YiEarly P1C (39)
PREDNISONE TABLETS
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
PREDNISONE TABLETS
T-Cell And NK-Cell Neoplasm
New York Medical CollegeEarly P1C (39)
Promethazine
CAR-T
Zhimin ZhaiEarly P1C (39)
PROPOFOL
ECT
Min SuEarly P1C (39)
PROPOFOL
Esketamine
Min SuEarly P1C (39)
PROPOFOL
Opioid Use Disorder
Jacques E. ChellyEarly P1C (39)
PROPRANOLOL
Primary Progressive Aphasia
University of Missouri-ColumbiaEarly P1C (39)
PROPRANOLOL
Epilepsy
Xuanwu Hospital, BeijingEarly P1C (39)
PROPRANOLOL
Vasodilation
University of Missouri-ColumbiaEarly P1C (39)
Psma-Hbed-Cc
PET/CT
Anhui Provincial HospitalEarly P1C (39)
Pu-H71
Plasma Cell Myeloma
Memorial Sloan Kettering Cancer CenterEarly P1C (39)
Showing 701 to 725 of 1,553 assets
PreviousPage 29 of 63Next